Cellbox Solutions

We’ve closed the first tranche of our Series A financing round, raising ~€3.5M led by @Companisto together with existing investors, including NRW.BANK. The funding will accelerate the global expansion of our warm-chain logistics platform for transporting living cells and new applications in life sciences. We’re also excited to welcome Dr. Bernd Muehlenweg as Chief Business Officer & Chief Financial Officer. Read the full press release here: cellbox-solutions.com/news/cellbox-s…

When environmental control and usability come together, cell logistics becomes more predictable and scalable across facilities. #celltransport #reproducibility

🧫 Modern cell transport requires more than environmental control. Practical usability and seamless workflow integration are becoming essential for predictable and scalable research operations across sites. #celltransport #reproducibility #lifescience

New year. New beginnings. Wishing everyone celebrating a joyful Lunar New Year ✨ #LunarNewYear

As cell therapies scale globally, manufacturing and logistics are becoming biologically relevant variables rather than purely operational ones. This work, developed together with Fraunhofer, highlights how transport conditions can shape downstream cell therapy performance. Worth a closer look. Link: doi.org/10.3389/fbioe.…

NK cell therapies are moving closer to routine clinical use, but logistics remain an underestimated variable. Comparative data suggest cryopreservation can reduce viability and functional cytotoxicity compared to controlled live transport conditions, highlighting how handling can directly influence therapeutic cell quality.

A concise and worthwhile read for researchers working in stem cells, organoids, and translational immunology. ➡️ rdcu.be/e3GB9

This could strengthen future cell-based immunotherapies and improve reliability of iPSC-derived immune cell manufacturing.

#ArticleoftheWeek A recent study in Nature Communications by Tsutsui et al. introduces a 3D organoid-based artificial thymus to improve generation of functional iPSC-derived immune cells. Another strong contribution from Kyoto’s iPSC ecosystem. Thread 👇

Learn about critical safety precautions including CO₂ handling, battery safety and transport best practices when operating the Cellbox™ Go. Episode 2 of our Cellbox™ Go Training Series is now available on YouTube 🎬🧪 Watch here 👉 youtube.com/watch?v=I7dLZ1… #celltherapy #atmp #biotech #lifesciences #celltransport

“By transporting our cells live under controlled incubatory conditions, we were able to incorporate transport time directly into our cell expansion protocols. This significantly improved anticipated cell viability and performance, saving our team roughly two months and keeping the project on track.” #celltherapy #ATMP #cellandgenetherapy

By maintaining full incubatory conditions during transport, transit time was integrated directly into the cell expansion process. This enabled immediate downstream processing upon arrival.

A mission that couldn’t wait. On extremely short notice, Cellbox Solutions supported the live transport of patient-derived MSCs for a therapy project intended for an infant patient in the U.S., where time was a critical factor.

We’ve launched Episode 1 of our Cellbox™ Go Training Series 🎬🧪 Learn how the Cellbox™ Go, a portable CO₂ incubator with active CO₂ and temperature control, supports the short- to mid-distance transport of cell-based materials and ATMPs. Watch here 👉 youtube.com/watch?v=r9ePxo… #celltherapy #atmp #biotech #lifesciences #celltransport

Link to the paper: cira.kyoto-u.ac.jp/e/research/kan…

This has clear relevance for future cell-based #immunotherapies. The paper is currently available as an early version of record, with the final edited article still pending. Congratulations to: @CiRA_KU_E

First #ArticleoftheWeek 🔔of 2026: A recent study by Shiina et al. reports a 3D organoid culture system that functions as an artificial thymus to generate functional iPSC-derived immune #cells. The platform supports maturation of CD4 iNKT cells with more consistent development than standard 2D cultures.